Dr. Foster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
MC 9006
Chicago, IL 60637Phone+1 570-573-2793
Summary
- Corey Foster, MD is a radiation oncologist based in Oak Lawn, IL, specializing in the treatment of cancer, particularly head and neck cancer. He completed his medical education cum laude at the University of Michigan Medical School, and his residency at the University of Chicago/ University of Illinois. Currently, he is a radiation oncologist at Affiliated Oncologists LLC, after a year as an Assistant Professor at Vanderbilt University Medical Center. He has published multiple papers on oncology, dealing with subjects such as HPV associated oropharyngeal cancer and immune related adverse events. He has also contributed to clinical trials for treating HPV related Oropharyngeal Cancer. Dr. Foster was recognized by the Alpha Omega Alpha Honor Medical Society in 2014.
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2016 - 2020
University of ChicagoMS, Public Health Sciences, 2018 - 2019
Christiana Care Health ServicesInternship, Transitional Year, 2015 - 2016- University of Michigan Medical SchoolDoctor of Medicine, Cum Laude, 2011 - 2015
- DeSales UniversityBS, Biology, Summa Cum Laude, 2011 - 2015
University of Michigan Medical SchoolClass of 2015
Certifications & Licensure
IL State Medical License 2021 - 2026
TN State Medical License 2020 - 2023- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha Honor Medical Society 2014
Clinical Trials
Publications & Presentations
PubMed
- Reply to "Guarantee-time bias in studies on the relationship between immune-related adverse events and antitumor activity".Corey C Foster, Tanguy Y Seiwert
Cancer. 2022-07-01 - 15 citationsRisk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience.Ari Rosenberg, Nishant Agrawal, Alexander T. Pearson, Zhen Gooi, Elizabeth A. Blair
Oral Oncology. 2021-10-18 - 45 citationsImmune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving i...Corey C. Foster, Marcus Couey, Sara Kochanny, Arun Khattri, Rajesh Acharya
Cancer. 2021-09-21
Journal Articles
- OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal CancerL Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology
Lectures
- Association of immune-related adverse events (irAEs) with improved response, progression-free survival, and overall survival for patients with metastatic head and neck...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Association of a baseline neutrophil-to-lymphocyte ratio (NLR) with progression-free and overall survival in head and neck cancer patients receiving anti-PD-1 therapy.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Authored Content
- Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer9/1/2017
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
